Evidence map›Paper›PMID 18436086›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2008

Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes.

Meda E Pavkov, William C Knowler, Robert L Hanson, Peter H Bennett, Robert G Nelson

Open access · greenAbstract read
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 5 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 5 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Segmental Sclerosis and Extracapillary Hypercellularity Predict Diabetic ESRD.Journal of the American Society of Nephrology : JASN · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Early renal function decline in type 2 diabetes.Clinical journal of the American Society of Nephrology : CJASN · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Meda E PavkovDiabetes Epidemiology and Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85014-4972, USA. mpavkov@cdc.gov
William C Knowler
Robert L Hanson
Peter H Bennett
Robert G Nelson
National Institute of Diabetes and Digestive and Kidney Diseases · USNational Institutes of Health · US

Funding

Epidemiology and Physiology of Diabetic NephropathyZ01DK069063 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KNOWLER, WILLIAM C · 1996 to 2008
$654k
Epidemiology and Physiology of Diabetic NephropathyZIADK069063 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KNOWLER, WILLIAM C · 2009 to 2011
$621k
Intramural NIH HHS Z01 DK069063
6 · The paper itself

Abstract

backgroundTo determine whether historic albuminuria measurements provide additional predictive value for diabetic end-stage renal disease (ESRD) and natural mortality over the most recent measurement, ie, whether "regression" from high albuminuria has a different prognosis than stability at the lower level. STUDY

designObservational longitudinal study. SETTING &

participantsPima Indians 15 years or older with type 2 diabetes and at least 2 consecutive measurements of urinary albumin-creatinine ratio (ACR) within 6 years. PREDICTORS: Sequential measurements of urinary ACR. OUTCOMES & MEASUREMENTS: Proportional hazards analyses were used to estimate the risk of ESRD and natural death associated with the first and second ACR measurement. The ability of these highly correlated variables to predict outcome was compared with receiver operating characteristic curves calculated by means of the generalized c statistic.

resultsIn 983 subjects, 136 developed ESRD and 180 died of natural causes during a maximum follow-up of 12.6 years. Each doubling in the second ACR was associated with a 1.71-fold greater incidence of ESRD (95% confidence interval, 1.54 to 1.89) and 1.16-fold greater natural mortality (95% confidence interval, 1.07 to 1.27) adjusted for age, sex, diabetes duration, and antihypertensive medication. The addition of the first ACR measurement to the model did not add to the predictive value for ESRD or mortality. In pairwise comparisons of c statistics, the second ACR was a significantly better predictor of ESRD than the first ACR. LIMITATIONS: The predictive value of ACR measurements is decreased to the extent that its precision is based on a single measure.

conclusionThe predictive power of the latest ACR for ESRD and natural mortality in patients with diabetes is not enhanced by knowledge of the preceding ACR. Therefore, ACR changes over time, ie, regression or progression, add minimal predictive value beyond the latest measurement in the series.

Indexed as

Indians, North AmericanAdultAlbuminuriaDiabetes Mellitus, Type 2Diabetic NephropathiesDisease ProgressionFemaleFollow-Up StudiesHumansKidney Failure, ChronicLongitudinal StudiesMaleMiddle AgedPredictive Value of Tests

Identifiers

PMID18436086
PMCPMC2386511
OpenAlexW2098863404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.